PANoptosis:对于心血管疾病来说是一个新的目标
Qi Xiang1, Zhen-Xi Geng1, Xin Yi2
1Division of Cardiovascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Trends in pharmacological sciences
|July 13, 2024
概括
炎症性细胞死亡途径PANoptosis是一个潜在的治疗点. 本综述探讨了它在心血管疾病和治疗策略中的作用,提供了一种新的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 心血管医学 心血管医学
背景情况:
- 泛光亡是一种独特的炎症性光细胞死亡途径.
- 它是由天生的免疫传感器启动的,涉及caspases和RIPKs.
- 与癌症和炎症状况相比,其在心血管疾病中的作用仍未得到充分探索.
研究的目的:
- 审查各种心血管疾病中PANoptosis的证据.
- 探索针对心血管疾病的PANoptosis的治疗剂.
- 提出PANoptosis作为心血管疾病的新型治疗点.
主要方法:
- 关于PANoptosis和心血管疾病研究的文献综述.
- 对针对PANoptosis的现有治疗策略的分析.
- 综合证据将PANoptosis与心肌病,动脉样硬化,心肌梗塞,心肌炎和大动脉动脉瘤/剖析联系起来.
主要成果:
- 泛光死在几个心血管疾病中起作用,包括心肌病,动脉样硬化,心肌梗塞,心肌炎和大动脉动脉瘤/剖析.
- 向PANoptosome组件提供了一种抑制这种细胞死亡途径的策略.
- 现有的研究主要集中在癌症和传染性/炎症性疾病上,对心血管影响的关注有限.
结论:
- 泛光亡是心血管疾病的一个重要因素.
- 向PANoptosis为心血管疾病提供了一个新的治疗途径.
- 对心血管疾病中PANoptosis的进一步研究是有必要的,以开发有效的治疗方法.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419


